Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk.

Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk. Abstract Text:

Takeshi Yoshida,Isamu Okamoto,Takafumi Okabe,Tsutomu Iwasa,Taroh Satoh,Kazuto Nishio,Masahiro Fukuoka,Kazuhiko Nakagawa,

Molecular inhibition of the epidermal growth factor receptor (EGFR) is a promising anticancer strategy, and monoclonal antibodies (mAbs) to EGFR are undergoing extensive evaluation in preclinical and clinical trials. However, the effects of anti-EGFR mAbs on EGFR signaling have remained unclear. We have now examined the effects of 2 anti-EGFR mAbs, matuzumab (EMD72000) and cetuximab (Erbitux), both of which are currently under assessment for treatment of various cancers, on EGFR signal transduction and cell survival in nonsmall cell lung cancer cell lines. Similar to EGF, matuzumab and cetuximab each induced phosphorylation of EGFR at several tyrosine phosphorylation sites as a result of receptor dimerization and activation of the receptor tyrosine kinase. In contrast to the effects of EGF, however, EGFR activation induced by these antibodies was not accompanied by receptor turnover or by activation of downstream signaling pathways that are mediated by Akt and Erk and are important for regulation of cell proliferation and survival. In addition, clonogenic survival assays revealed that matuzumab and cetuximab reduced the survival rate of H292 cells, in which they also inhibited the EGF-induced activation of Akt and Erk. Although we have examined only a few cell lines, our results indicate that the antitumor effects of matuzumab and cetuximab depend on inhibition of EGFR downstream signaling mediated by Akt or Erk rather than on inhibition of EGFR itself.

Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk. Publishing Authors By Initials

T Yoshida,I Okamoto,T Okabe,T Iwasa,T Satoh,K Nishio,M Fukuoka,K Nakagawa,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: International journal of cancer. Journal internati

VOLUME: 122

Page Numbers: 1530-8

Journal Abbreviation: Int. J. Cancer

ISSN: 1097-0215

DAY: 1

MONTH: Apr

YEAR: 2008

Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 42124

Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk.

AFFILIATION: Department of Medical Oncology, Kinki University School of Medicine, Osaka, Japan.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Int J Cancer

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk Related Publications

• 11-Deoxyalisol C and Alisol D: New Protostane-Type Triterpenoids from Alisma plantago-aquatica.
• A case of angioedema associated with decreased C1 inhibitor activity.
• A neural network model of metaphor understanding with dynamic interaction based on a statistical language analysis: targeting a human-like model.
• An adult form of Alexander disease: a novel mutation in glial fibrillary acidic protein.
• Characterization of progenitor domains in the developing mouse thalamus.
• Delay of cataract development in the shumiya cataract rat by the administration of drinking water containing high concentration of magnesium ion.
• Effects of frequency characteristics of reverberation time on listener envelopment.
• Efficacy of living donor liver transplantation for patients with methylmalonic acidemia.
• Efficient generation of antigen-specific cellular immunity by vaccination with poly(gamma-glutamic acid) nanoparticles entrapping endoplasmic reticulum-targeted peptides.
• Fractal-based EEG data analysis of body parts movement imagery tasks.
• Fructose, but not dextrose, accelerates the progression of chronic kidney disease.
• Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit.
• Glutathione S-transferase M1 null genotype as a risk factor for carbamazepine-induced mild hepatotoxicity.
• Impact of CYP2D6*10 on H1-antihistamine-induced hypersomnia.
• In Situ Detection of Surface SiH(n) in Synchrotron-Radiation-Induced Chemical Vapor Deposition of a-Si on an SiO(2) Substrate.
• Interfacility transport of the critically ill pediatric patient.
• New Secoiridoid Glucosides from Ligustrum japonicum.
• Nuclear translocation of ADAM-10 contributes to the pathogenesis and progression of human prostate cancer.
• Overexpression of RGPR-p117 suppresses apoptotic cell death and its related gene expression in cloned normal rat kidney proximal tubular epithelial NRK52E cells.
• Pulse radiolysis study on free radical scavenger edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one).
• Rectified momentum transport for a kicked Bose-Einstein condensate.
• TERT promoter-driven adenovirus vector for cancer gene therapy via systemic injection.
• The mRNA-like noncoding RNA Gomafu constitutes a novel nuclear domain in a subset of neurons.
• Thiazide diuretics exacerbate fructose-induced metabolic syndrome.
• Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease.
• [A patient with small cerebellar infarcts at tonsil and nodulus who complained of vertigo, vomiting and chest oppression]
• [Biological characteristics of an established model of ovarian cancer in mice and its homologous cell lines]
• [Coronary artery aneurysm]
• [Myocardial infarction in young patients]
• [Position of NSAIDs in causal factors of peptic ulcer]